Pharmacokinetic considerations for current state-of-the-art antidepressants
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic considerations for current state-of-the-art antidepressants
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2019-09-18
DOI
10.1080/17425255.2019.1669560
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognosis and improved outcomes in major depression: a review
- (2019) Christoph Kraus et al. Translational Psychiatry
- Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe
- (2019) Jelena Petrović et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
- (2018) Marin M. Jukić et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
- (2018) Andrea Cipriani et al. LANCET
- Depression
- (2018) Gin S Malhi et al. LANCET
- Sertraline in pregnancy – Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood
- (2017) Michael Paulzen et al. JOURNAL OF AFFECTIVE DISORDERS
- Adaptive dynamics of the 5-HT systems following chronic administration of selective serotonin reuptake inhibitors: a meta-analysis
- (2017) Stefan Fritze et al. JOURNAL OF NEUROCHEMISTRY
- Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
- (2017) C. Hiemke et al. PHARMACOPSYCHIATRY
- Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD)
- (2017) Shiv Gautam et al. Indian Journal of Psychiatry
- Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid
- (2016) Valentina M. Fokina et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review
- (2016) Antonio Bruno et al. Current Neuropharmacology
- Prediction of CYP2D6 phenotype from genotype across world populations
- (2016) Andrea Gaedigk et al. GENETICS IN MEDICINE
- P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood–brain barrier in vivo
- (2016) Christoffer Bundgaard et al. NEUROPHARMACOLOGY
- Pharmacokinetics and Safety of Vilazodone in Hepatic Impairment
- (2015) Ramesh Boinpally et al. AMERICAN JOURNAL OF THERAPEUTICS
- The promise of ketamine for treatment-resistant depression: current evidence and future directions
- (2015) Kaitlin E. DeWilde et al. Annals of the New York Academy of Sciences
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
- (2015) Gin S Malhi et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects
- (2015) Laishun Chen et al. CLINICAL DRUG INVESTIGATION
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
- (2015) JK Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibition
- (2015) Laishun Chen et al. CLINICAL THERAPEUTICS
- Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans
- (2015) Laishun Chen et al. Drug Design Development and Therapy
- Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation
- (2014) B. H. Mullish et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy Individuals
- (2014) Johan Areberg et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Effect of Hepatic Impairment on the Pharmacokinetics of Levomilnacipran Following a Single Oral Dose of a Levomilnacipran Extended-Release Capsule in Human Participants
- (2014) Laishun Chen et al. CLINICAL DRUG INVESTIGATION
- Influence of CYP3A4 Induction/Inhibition on the Pharmacokinetics of Vilazodone in Healthy Subjects
- (2014) Ramesh Boinpally et al. CLINICAL THERAPEUTICS
- Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants
- (2014) Domenico Italiano et al. Expert Opinion on Drug Metabolism & Toxicology
- Clinically relevant interactions between newer antidepressants and second-generation antipsychotics
- (2014) Edoardo Spina et al. Expert Opinion on Drug Metabolism & Toxicology
- CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation
- (2014) Yingying Kumar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies
- (2013) et al. AMERICAN JOURNAL OF PSYCHIATRY
- The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram
- (2013) Fionn E. O’Brien et al. BEHAVIOURAL BRAIN RESEARCH
- Pharmacokinetics of Vilazodone in Patients with Mild or Moderate Renal Impairment
- (2013) Ramesh Boinpally et al. CLINICAL DRUG INVESTIGATION
- Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
- (2013) Grace Chen et al. CLINICAL DRUG INVESTIGATION
- The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder
- (2013) Reinhard Heun et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression
- (2013) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHIATRY
- Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety
- (2013) A.L. Auclair et al. NEUROPHARMACOLOGY
- Age-Related Changes in Antidepressant Pharmacokinetics and Potential Drug-Drug Interactions: A Comparison of Evidence-Based Literature and Package Insert Information
- (2012) Richard D. Boyce et al. American Journal Geriatric Pharmacotherapy
- Vilazodone: A novel antidepressant
- (2012) E. Choi et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats
- (2012) FE O'Brien et al. BRITISH JOURNAL OF PHARMACOLOGY
- An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator
- (2012) Kristina A. Coleman et al. CNS SPECTRUMS
- Therapeutic Drug Monitoring for Antidepressant Drug Treatment
- (2012) Elnaz Ostad Haji et al. CURRENT PHARMACEUTICAL DESIGN
- Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)*
- (2012) Evi V. Nagler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings
- (2011) Fionn E O'Brien et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers
- (2011) Alice I. Nichols et al. CLINICAL DRUG INVESTIGATION
- Duloxetine
- (2011) Mary Pat Knadler et al. CLINICAL PHARMACOKINETICS
- Clinically Significant Drug Interactions with Newer Antidepressants
- (2011) Edoardo Spina et al. CNS DRUGS
- Age-Related Changes in Pharmacokinetics
- (2011) Shaojun Shi et al. CURRENT DRUG METABOLISM
- A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease
- (2011) S. Susan Hedayati et al. KIDNEY INTERNATIONAL
- A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
- (2010) Michele Fornaro et al. Current Neuropharmacology
- Antidepressant Exposure as a Predictor of Clinical Outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) Study
- (2010) Dara J. Sakolsky et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Postpartum depression
- (2009) Teri Pearlstein et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Antidepressant Medication Use During Breastfeeding
- (2009) TERESA LANZA DI SCALEA et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Pharmacogenetics in Psychiatry - A Useful Clinical Tool or Wishful Thinking for the Future?
- (2009) J. Kirchheiner et al. CURRENT PHARMACEUTICAL DESIGN
- Identification of Cytochrome P450 Isoforms Involved in the Metabolism of Paroxetine and Estimation of Their Importance for Human Paroxetine Metabolism Using a Population-Based Simulator
- (2009) J. Jornil et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics and drug metabolism in the elderly
- (2009) Ulrich Klotz DRUG METABOLISM REVIEWS
- Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
- (2009) Arif Khan EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Placental Transfer of SSRI and SNRI Antidepressants and Effects on the Neonate
- (2009) J. Rampono et al. PHARMACOPSYCHIATRY
- Desvenlafaxine
- (2009) Chittaranjan Andrade Indian Journal of Psychiatry
- Agomelatine Treatment of Major Depressive Disorder
- (2008) Christian R Dolder et al. ANNALS OF PHARMACOTHERAPY
- Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice
- (2008) M Kreilgaard et al. BRITISH JOURNAL OF PHARMACOLOGY
- Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography–mass spectrometry
- (2008) Sarah M. R. Wille et al. INTERNATIONAL JOURNAL OF LEGAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now